A longitudinal study of ICD-11 PTSD and Complex PTSD in the general population of Israel by Hyland, Philip et al.
1 




A longitudinal study of ICD-11 PTSD and Complex PTSD in the general population of Israel 
 
Philip Hylanda, Thanos Karatziasb,c, Mark Shevlind, Marylène Cloitree,f, & Menachem Ben-Ezrag 
a Department of Psychology, Maynooth University, Kildare, Ireland 
b Edinburgh Napier University, School of Health & Social Care, Edinburgh, UK 
c NHS Lothian, Rivers Centre for Traumatic Stress, Edinburgh, UK 
d School of Psychology, Ulster University, Derry, Northern Ireland 
e National Center for PTSD Dissemination and Training Division, VA Palo Alto Health Care 
System, Palo Alto, CA, USA. 
f Department of Psychiatry and Behavioural Sciences, Stanford University, Stanford, CA, USA.  





Running Head: Longitudinal study of ICD-11 PTSD and CPTSD 
Tables and Figures: 4 
Corresponding Author: Philip Hyland, Department of Psychology, Maynooth University, 
Kildare, Ireland. Philip.hyland@mu.ie. Phone: 0035314747374 
Disclosures: Each author has no financial relationships with commercial interests nor any 






Running Head: LONGITUDINAL STUDY OF PTSD AND CPTSD 
Abstract 
The ICD-11 includes two trauma disorders: Posttraumatic Stress Disorder (PTSD) and Complex 
PTSD (CPTSD). CPTSD is a disorder comprised of PTSD and Disturbance in Self-Organization 
(DSO) symptoms. Evidence supports the construct validity of PTSD and CPTSD, however, the 
temporal stability of these constructs has rarely been tested. This study examined the diagnostic 
stability of PTSD and CPTSD, and the temporal associations between PTSD and DSO symptoms 
over a period of one-year. Data were collected from a nationally representative sample of Israeli 
adults (n = 1,003) and one year later a random half of this sample were reassessed (n = 543). 
There were no statistically significant changes in rates of PTSD (6.7%, 5.3%) and CPTSD 
(4.9%, 3.7%) over time. Latent variable cross-lagged analysis indicated that PTSD and DSO 
symptoms were stable over time and that DSO symptoms predicted subsequent PTSD symptoms. 
Results suggest that ICD-11 PTSD and CPTSD are stable constructs in the general population 
over a period of one year. We discuss the possibility that these findings are influenced by the 
specific cultural context of Israel. Additionally, given the stability and influence of DSO 
symptoms we discuss the potential value of psychological therapies that directly address these 
symptoms.  
Key words: trauma; PTSD; Complex PTSD; ICD-11; longitudinal; cross-lagged analysis. 
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Highlights 
1. 11.6% (T1) and 9.0% (T2) of the general population of Israel met diagnostic requirements for 
ICD-11 PTSD and Complex PTSD.  
2. The prevalence rates of PTSD and Complex PTSD remained stable over the course of one 
year.  
3. DSO symptoms are persistent over time and reinforce and intensify PTSD symptoms. 
4. Clinical interventions that specifically address DSO symptoms may be of value. 
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1.1 Introduction 
The 11th version of the International Classification of Diseases (ICD-11) includes 
Posttraumatic Stress Disorder (PTSD) and Complex PTSD (CPTSD) as related-but-distinct 
diagnoses (World Health Organization [WHO], 2018). Both disorders require exposure to an 
event of an extremely threatening or horrific nature for the consideration of a diagnosis, and 
CPTSD is more likely to occur following exposure to multiple or prolonged traumatic events, 
particularly those that occur during early development (WHO, 2018; Brewin et al., 2017; Cloitre 
et al., 2019). A PTSD diagnosis is made if at least one symptom is present from the clusters of 
‘Re-experiencing in the here and now’, ‘Avoidance’, and ‘Sense of Threat’ and these symptoms 
are associated with impaired functioning. A CPTSD diagnosis is made if all PTSD criteria are 
met and at least one symptom is present from the three Disturbance in Self-Organization (DSO) 
clusters of ‘Affective Dysregulation’, ‘Negative Self-Concept’, and ‘Disturbed Relationships’. 
These symptoms must also be associated with impaired functioning.  
Empirical support for the construct validity of ICD-11 PTSD and CPTSD has come from 
general population (Ben-Ezra et al., 2018; Cloitre et al., 2019; Karatzias et al., 2019), clinical 
(Hyland et al., 2017; Karatzias et al., 2016), and refugee samples (Shevlin et al., 2018; Vallières 
et al., 2018) from around the world. The overwhelming majority of existing evidence, however, 
comes cross-sectional data and consequently little is known about the temporal stability of the 
symptoms and diagnoses of PTSD and CPTSD. Barbano et al. (2019) reported changes in rates 
of (ICD-11) PTSD among survivors of non-interpersonal traumas from three weeks post-trauma, 
on average, to four-and-a-half months post-trauma, on average. PTSD declined from 39.7% to 
14.6%, reflecting the well-evidenced natural recovery process that occurs within the first months 
following traumatic exposure (e.g., Galatzer-Levy et al., 2013; Hepp et al., 2008). Although 
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highly informative, these findings are limited as PTSD was assessed using a proxy measure (the 
CAPS-IV) rather than an ICD-11 specific measure such as the International Trauma 
Questionnaire (ITQ: Cloitre et al., 2018) meaning that the DSO symptoms were not assessed. 
Thus, it was impossible to determine how many people classified as having a PTSD diagnosis 
actually met diagnostic criteria for CPTSD. Furthermore, because many of the survivors were 
first assessed less than three weeks post-trauma, it is likely that the diagnostic rate at the first was 
over-estimated. 
In this study we measured PTSD and DSO symptoms with the ITQ at two points across a 
12-month period among a nationally representative sample of the Israeli adult population. The 
first objective was to test if there were statistically significant changes in rates of PTSD and 
CPTSD over the period of one year, and the second objective was to examine the temporal 
associations between the PTSD and DSO symptoms. Given the lack of available data and theory 
regarding the temporal stability of these diagnoses and the temporal relationships between the 
PTSD and DSO symptoms, no hypotheses were formulated, and an exploratory approach was 
adopted.  
2. Methods 
2.1 Participants and procedures 
Participants were recruited from a nationally representative internet panel of Israeli adults 
(N = 130,000). The internet panel matches demographic information provided by the Israeli 
Bureau of Statistics (Bodas et al., 2018). At the first assessment (T1), a nationally representative 
sample of 1,003 adults were recruited. The participation rate was 31%. Twelve months later 
(T2), approximately 50% of the original sample were re-assessed (n = 543). The decision to only 
re-assess a subset of the original sample was due to resource constraints. The participants at T2 
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were selected on a random basis from the original sample and were contacted by the survey 
company and asked to participate in a second assessments. We do not have data regarding the 
participation rate at T2. At both assessments, participants were contacted by the survey company 
via email and at T1 participants were informed that they may be contacted again in the future to 
participate in a second round of assessments. If participant chose to participate, they followed a 
link to a secure website where they were required to provide informed consent to participate 
before completing any measures. Ethical approval for the collection of these data was provided 
by the ethical review board to which the final author is affiliated. All procedures contributing to 
this work complied with the ethical standards of the relevant national and institutional 
committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 
2008. Inclusion criteria were that participants were over the age of 18 at the time of initial 
contact and were fluent in Hebrew. Additionally, all participants were considered to be trauma-
exposed as Israeli citizens live under a direct or potential threat to life due to the ongoing armed-
conflict in the Middle East, and thus satisfy the typical description of trauma exposure. 
The mean age of the sample at T1 was 40.57 years (SD = 14.53, range 18-70) and 51.7% 
(n = 519) were female. The majority of participants lived in an urban area (82.3%, n = 825), 
were in a committed relationship (70.5%, n = 707), were in full- or part-time employment 
(82.7%, n = 830), and had completed a university level education (68.4%, n = 686). Participants 
at T2 did not significantly differ from non-participants in terms of sex (χ2 (1) = 1.62, p = .204, 
phi = .04), urbanicity (χ2 (1) = 0.00, p = .952, phi = .00), relationship status (χ2 (1) = 3.39, p = 
.066, phi = .06), employment status (χ2 (3) = 3.45, p = .327, phi = .06), or education status (χ2 (3) 
= 7.23, p = .065, phi = .09). Additionally, no significant differences were observed between 
those who participated at T2 and those who did not on the number of reported traumatic life 
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events (t (1001) = 0.81, p = .416, d = .05), PTSD symptoms (t (1001) = 1.36, p = .174, d = .08), 
or DSO symptoms (t (1001) = 0.51, p = .607, d = .03).  
2.2 Measures 
2.2.1 Traumatic Exposure 
Lifetime exposure to 18 different traumatic events was measured using a modified 
version of the Life Events Checklist for DSM-5 (LEC-5: Weathers et al., 2013). In this study, 
two additional questions were added to the list of 16 LEC-5 events in order to measure childhood 
physical assault and childhood sexual assault. Respondents were instructed to indicate whether 
each event “Happened to me”, “Witnessed it”, “Learned about it”, “Part of my job”, “Not Sure”, 
or “Doesn’t apply”. Responses of “Happened to me” or “Witnessed it” were used to reflect 
exposure to each event, and all other responses reflected non-exposure. The number of traumatic 
life events ranged, therefore, from 0-18. The LEC-5 also asks a respondent to identify which 
event was most distressing, and how long ago this event occurred. The LEC-5 was completed at 
T1 but not at T2.  
2.2.2 ICD-11 PTSD and CPTSD 
The ITQ (Cloitre et al., 2018) is a self-report measure designed to capture the ICD-11 
diagnoses of PTSD and CPTSD. At both assessments, the Hebrew translation of the ITQ was 
used and both versions can be freely accessed here: https://www.traumameasuresglobal.com/itq. 
The psychometric properties of the Hebrew translation of the ITQ were demonstrated in a 
previous study based on responses from the T1 assessment of this study (Ben-Ezra et al., 2018). 
Consistent with findings from the English version of the ITQ (Cloitre et al., 2018; Hyland et al., 
2017; Karatzias et al., 2016), the latent structure of the Hebrew translation is best represented by 
a higher-order model including two second-order factors (‘PTSD’ and ‘DSO’) capturing the 
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covariation between the first-order factors of ‘Re-experiencing in the here and now’, 
‘Avoidance’ and ‘Threat’ (PTSD), and, ‘Affective Dysregulation’, ‘Negative Self-Concept’, and 
‘Disturbed Relationships’ (DSO), respectively. 
The ITQ instructs participants to complete the questionnaire in relation to their most 
distressing traumatic event. The ITQ includes six items measuring each PTSD symptom (T1 α = 
.89; T2 α = .90) and six items measuring each DSO symptom (T1 α = .88; T2 α = .89). 
Additionally, three items measure functional impairment (in the domains of social, occupational, 
and other important areas of life) related to the PTSD and DSO symptoms, respectively. 
Individuals respond to each PTSD item in terms of how much they have been bothered by that 
symptom over the past month, and to each DSO item in terms of how they typically feel, think 
about themselves, and relate to others. All items are measured using a five-point Likert scale 
ranging from 0 (Not at all) to 4 (Extremely). PTSD and DSO symptoms range from 0-24 with 
higher scores reflecting greater symptomatology. For diagnostic purposes, a symptom was 
deemed to be ‘present’ based on a Likert score of > 2 (Moderately) (Cloitre et al., 2018).  
2.3 Data analysis 
The proportions of people meeting diagnostic criteria for PTSD and CPTSD at T1 and T2 
were compared using McNemar’s exact binomal test. Paired samples t-tests were used to 
compare PTSD and DSO symptoms (total and subscale scores) across the two assessments. To 
adjust for an increased likelihood of a Type-1 error as a result of multiple testing, a Bonferroni 
correction was applied (0.05 / 8 = 0.006). Effect sizes were calculated using Cohen’s d corrected 
for repeated measures (drm) and values < .40 reflect small effects, values from .40-.80 reflect 
medium effects, and values > .80 reflect large effects (Morris, 2008). 
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The temporal associations between the PTSD and DSO symptoms were assessed using 
latent variable cross-lagged analysis. The PTSD latent variable was estimated using summed 
scores from the Re-experiencing, Avoidance, and Sense of Threat clusters, and the DSO latent 
variable was estimated using summed scores from the Affective Dysregulation, Negative Self-
Concept, and Disturbed Relationships clusters. Four nested models were tested (Figure 1). Model 
1 included only autoregressive paths for PTSD and DSO and tested the concept that these 
symptoms predict themselves but not one another over time. Model 2 included only cross-lagged 
paths between PTSD and DSO and tested the concept that these symptoms predict each other but 
not themselves over time. Model 3 included autoregressive and cross-lagged paths for PTSD and 
DSO and tested the concept that these symptoms predict themselves and one another over time. 
Model 4 imposed equality constraints on the cross-lagged paths between PTSD and DSO and 
tested the concept that both sets of symptoms were equally predictive of one another over time.  
These models were tested with the factor loadings at T1 and T2 freely estimated (Models 
1a, 2a, 3a, and 4a) and with the factor loadings constrained to be equal over time (Models 1b, 2b, 
3b, and 4b). Constraining the factor loadings to be equal across the two assessments tests the 
assumption of metric invariance. If the models with equal factor loadings fit the data as well as 
or better than the models with freely estimated factor loadings the assumption of metric 
invariance is satisfied. Satisfying the assumption of metric invariance demonstrates that the same 
constructs are being measured at both assessments (van de Schoot, Lugtig, & Hox, 2012). All 
models were adjusted for age, sex, time since exposure to one’s worst trauma (‘time’), and the 
total number of traumatic life events (‘traumas’). These covariates were measured at T1 and the 
PTSD and DSO latent variables at T1 and T2 were regressed onto the covariates. The PTSD and 
DSO latent variables were free to correlate at both assessments.  
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 The cross-lagged models were estimated using the robust maximum likelihood estimator 
(Yuan & Bentler, 2000) in Mplus 8.2 (Muthén & Muthén, 2017). Missing data were managed 
using the full information maximum likelihood function meaning that the analyses were based on 
all available data from the T1 assessment (Cham et al., 2017). Determination of model fit 
followed standard recommendations whereby satisfactory fit was indicated by a non-significant 
chi-square (χ2) result; Comparative Fit Index (CFI) and Tucker-Lewis Index (TLI) values > .90; 
and Root-Mean Square Error of Approximation (RMSEA) and Standardized Root Mean Square 
Residual (SRMR) values < .08 (Hu & Bentler, 1999). The four nested models were compared 
using the Akaike Information Criterion (AIC) where lower values indicate superior model fit.  
Metric invariance was assessed in accordance with Chen’s (2007, p. 501) recommendations for 
large sample sizes (N > 300) where “…a change of > -.010 in CFI, supplemented by a change of 
> .015 in RMSEA or a change of > .030 in SRMR would indicate noninvariance”. 
Figure 1 here 
3. Results 
3.1 Descriptive statistics 
The mean number of traumatic life events was 4.35 (SD = 3.01) and the event most 
commonly identified as the most distressing was the ‘unexpected death of a loved one’ (23.5%). 
Approximately half of the participants (50.8%) experienced their most distressing trauma more 
than ten years ago, 37.8% experienced their trauma between one and ten years ago, and 11.4% 
experienced their trauma in the year prior to the first assessment. 
At T1 6.7% (95% CIs = 4.2%, 8.3%) met diagnostic requirements for PTSD and 4.9% 
(95% CIs = 2.4%, 5.7%) for CPTSD. At T2 5.3% (95% CIs = 3.4%, 7.2%) met requirements for 
PTSD and 3.7% (95% CIs = 2.1%, 5.3%) for CPTSD. A McNemar’s exact binomial test found 
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no statistically significant change in diagnostic rates of PTSD (p = .576) and CPTSD (p = .851) 
across the two assessments.  
In order to ensure that the observed changes in the PTSD and CPTSD diagnostic rates 
were not due to re-sampling bias, the T1 diagnostic rates were calculated among only for those 
who participated at T2 (n = 543). The PTSD (6.3%, 95% CIs = 4.2%, 8.3%) and CPTSD (4.1%, 
95% CIs = 2.4%, 5.7%) rates were extremely similar to the estimates for the full sample and the 
confidence intervals were identical. 
The changes in the mean PTSD and DSO symptoms (as well as their constituent 
symptom clusters) from T1 to T2 are presented in Table 1. PTSD symptoms significantly 
declined; however, the magnitude of this decline was small (d = .14, p < .001). The decline in 
PTSD symptoms was attributable to a change in Sense of Threat symptoms specifically (d = .16, 
p < .001). There were no statistically significant changes in the total or subscale DSO symptoms. 
Table 1 here 
3.2 Cross-lagged model results  
Model fit results for the cross-lagged models are presented in Table 2. The changes in 
CFI, RMSEA, and SRMR between the models with freely estimated factor loadings and equal 
factor loadings (i.e., 1a vs. 1b, 2a vs. 2b etc.) supported the assumption of metric invariance 
across time. Thus, the four models with equal factor loadings were subsequently compared.   
Model 1b (autoregressive paths only) provided a satisfactory representation of the data 
whereas Model 2b (cross-lagged paths only) provided an unsatisfactory representation of the 
data. Model 3b (autoregressive paths and freely estimated cross-lagged paths) had a lower AIC 
value than Model 1b indicating an improvement in fit following the inclusion of the cross-lagged 
paths between PTSD and DSO. Model 4b (autoregressive paths and equal cross-lagged paths) 
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had a higher AIC value than Model 3b indicating that the cross-lagged paths between PTSD and 
DSO were not equivalent.  
Table 2 here 
 As presented in Figure 2, the factor loadings for PTSD and DSO at T1 and T2 were all 
significant (p < .001), positive, and strong (λ > .70). The DSO autoregressive path (β = .79, p < 
.001) was greater than the PTSD autoregressive path (β = .39, p < .001). T1 DSO positively 
predicted T2 PTSD (β = .19, p = .012), and T1 PTSD negatively predicted T2 DSO (β = -.18, p = 
.007). The correlations between PTSD and DSO at T1 (r = .53, p < .001) and T2 (r = .59, p < 
.001) were strong.  
Females had higher levels of PTSD (β = .18, p < .001) and DSO (β = .08, p = .014) at T1, 
and higher levels of PTSD (β = .14, p = .001) and DSO (β = .08, p = .043) at T2. Age was 
negatively associated with DSO at T1 (β = -.10, p = .003) and T2 (β = -.08, p = .049). Time 
passed since trauma exposure was negatively associated with T1 PTSD scores (β = -.19, p < 
.001) and positively associated with T2 PTSD scores (β = .09, p = .025). Exposure to a greater 
number of traumatic life events was positively associated with PTSD at T1 (β = .35, p < .001) 
and T2 (β = .14, p = .004), as well as with DSO at T1 (β = .30, p < .001) and T2 (β = .10, p = 
.042). 
Figure 2 here 
As a supplementary analysis, an additional test of scaler invariance was conducted to 
assess the invariance of the PTSD and DSO indicators over time, and then test for differences in 
the PTSD and DSO latent variable means over time. When the corresponding PTSD and DSO 
indicator intercepts were constrained to be equal at T1 and T2 the fit of the model was acceptable 
(χ2 (94) = 406.58, p < .001; RMSEA=.058 (95% CIs = .052 - .063); CFI = .982; TLI = .903; 
13 
Running Head: LONGITUDINAL STUDY OF PTSD AND CPTSD 
SRMR = .052). Based on Chen’s (2007) guidelines for determining scalar invariance, the change 
in the fit statistics between the model with intercepts freely estimated and the model with the 
intercepts constrained equal supported the invariance of intercepts (∆CFI= -.012; 
∆RMSEA=.002; ∆SRMR=.01). Subsequently, the PTSD and DSO latent variable means at T1 
were fixed to zero and the latent variable means at T2 were estimated. The T2 mean for PTSD 
was significantly lower than T1 (M = -1.10, SE = .25, p < .001) but there was no significant 
difference for DSO (M = -0.01, SE = .28, p = .959). These estimates are consistent with the mean 
changes reported in Table 1. 
4. Discussion 
We found that 11.6% and 9.0% of the general adult population of Israel met the 
diagnostic requirements for ICD-11 PTSD or CPTSD at the first and second assessments, 
respectively. Previous studies from Israel that employed self-report measures of DSM-IV PTSD 
found that rates varied between 8.8% and 10.1% (see Hoffman, Diamond, & Lipsitz, 2011 for a 
review). This suggests that the ICD-11 criteria identify a very similar proportion of diagnostic 
cases as the DSM-IV within the general population. This result is consistent with findings from 
the United States where 7.2% of the adult population met criteria for ICD-11 PTSD or CPTSD 
(Cloitre et al., 2019); a prevalence rate consistent with estimates of DSM-IV (Kessler et al. 1995; 
Kessler et al., 2005) and DSM-5 (Goldstein et al., 2016) PTSD.   
We found no statistically significant change in the rates of PTSD and CPTSD across the 
12-month assessment period. This is inconsistent with the findings of Barbano et al. (2019) who 
reported substantial reductions in PTSD rates. These inconsistent findings are almost certainly a 
consequence of the differences in when participants were assessed following their trauma 
exposure. Unlike the recently traumatised group assessed by Barbano and colleagues, the vast 
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majority (88.6%) of participants in this study experienced their index trauma event more than 
one year prior to their assessment, with half experiencing their index trauma more than a decade 
prior to their assessment. Collectively, these findings suggest that recovery from (ICD-11) PTSD 
is common in the first months after traumatic exposure but as time passes natural recovery from 
PTSD and CPTSD is unlikely. 
Our results showed that PTSD was slightly more common than CPTSD at both 
assessments, however, the confidence intervals for the two diagnoses overlapped at both 
assessments meaning that PTSD was not significantly more common than CPTSD. These 
findings are similar and distinct from findings from other nations. For example, in the United 
States, rates of PTSD (3.4%) and CPTSD (3.8%) were very similar (Cloitre et al., 2019); in 
Ireland, CPTSD (7.7%) was more common than PTSD (5.0%) but not significantly so (Hyland et 
al., 2020); and in a trauma-exposed sample from the United Kingdom, CPTSD (12.9%) was 
significantly more common than PTSD (5.3%). Collectively, these data indicate that CPTSD is 
not a rare condition in the general population and may occur at least as frequently as PTSD. 
Moreover, the variability in relative rates of PTSD and CPTSD across nations may be 
attributable to specific cultural factors within each country. The slightly higher rate of PTSD – a 
primary fear-based disorder – in Israel, for example, may be due to the fact that the Israeli 
population lives under the ongoing threat of rocket and terrorist attacks. This interpretation 
should be viewed cautiously in light of the fact that PTSD rates were not significantly higher 
than rates of CPTSD, however, recognizing the role that cultural and contextual factors play in 
the presentation of trauma responses may improve our understanding of these disorders and the 
best ways to intervene to prevent and treat them (Vallières et al., 2016).  
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 The paired samples t-test results showed that the only symptom cluster to significantly 
change over time was Sense of Threat, although the decline was very small. There are several 
possible explanations for this change: (1) it may reflect a naturally occurring decline in threat-
related symptoms, possibly driven by the small proportion of recently traumatised (i.e., in the last 
year) participants in the sample; (2) it may be the result of the increased safety in Israel across 
the study period where the number of terrorist related attacks continued its sharp decline since 
2015; or (3) it may simply reflect a Type-1 error. Given that the change was so small, we caution 
against over-interpreting this result. The overwhelming trend was one of stability over time.  
This stability of PTSD and DSO symptoms was also demonstrated by the results of the 
cross-lagged analyses. Specifically, the strength of the autoregressive paths for PTSD and DSO 
indicated that these symptoms were strongly self-reinforcing. The DSO symptoms were 
particularly stable over time and this is consistent with the conceptualization of DSO symptoms 
as ‘severe and persistent’ indicators of distress (WHO, 2018). Although stable, the PTSD and 
DSO symptoms did influence one another across time. Cross-sectional studies have shown these 
symptoms to be strongly and positively associated with one another (Brewin et al., 2017), 
however, the temporal effects observed in this study suggests a less straightforward relationship. 
The negative effect of T1 PTSD symptoms on T2 DSO symptoms was perplexing as it suggests 
that higher levels of PTSD predict slightly lower levels of DSO one year later. We suspected that 
this counterintuitive effect likely occurred because T1 DSO scores accounted for so much of the 
variance in T2 DSO scores (i.e., the strong autoregressive effect). As such, we examined the 
bivariate association between T1 PTSD and T2 DSO scores and found them to be positively 
correlated (r = .35, p < .001). Thus, we believe that the negative temporal effect from T1 PTSD 
symptoms to T2 DSO symptoms in the cross-lagged model was due to multicollinearity in the 
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model. It was telling that T1 DSO scores positively predicted T2 PTSD scores and we believe 
this effect was possible because T1 PTSD scores accounted for much less of the variance in T2 
PTSD scores (i.e., the weaker autoregressive effect). A plausible interpretation of these results, 
therefore, is that PTSD and DSO symptoms do have some influence on one another over time; 
that DSO symptom likely reinforce and intensify PTSD symptoms over time; and although 
PTSD symptoms may have a small effect on later DSO symptoms, it is likely that once the DSO 
symptoms are established they remain largely self-perpetuating.  
These findings have several important clinical and diagnostic implications. First, the 
stability of the DSO symptoms suggests that interventions other than those that have been 
established for the fear-based symptoms that characterise PTSD (such as exposure) may be 
required, or, a longer course of treatment may be beneficial (Karatzias et al., 2019). Such 
speculations, of course, require empirical testing. Second, PTSD symptoms are required for a 
diagnosis of CPTSD, however, given that these symptoms may be more likely to naturally 
decline than the DSO symptoms, it is conceivable that clinicians will encounter patients who 
have high DSO symptoms and low PTSD symptoms. This may be especially likely if the 
traumatic event occurred in the distant past. Such patients may be conceptualized as experiencing 
‘sub-clinical CPTSD’. Such patients may benefit more from psychological interventions that 
specifically target and treat DSO symptoms such as Skills Training for Affective and 
Interpersonal Regulation (Hassija & Cloitre, 2015). Further research is required to determine 
how common sub-clinical cases of CPTSD are in the population, and in clinical settings, and the 
optimal method to treat such patients.  
4.1 Limitations 
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These results should be interpreted with several limitations in mind. First, we could only 
recruit approximately half of the original sample for the follow-up assessment. While we cannot 
completely rule out the possibility that our results were influenced by sampling bias, we 
attempted to minimise this possibility by randomly selecting participants from the original 
sample. Second, cross-lagged panel model analysis has been criticised due to its inability to 
distinguish between the within- and between-person effects; a limitation that can result in biased 
estimates of the presence, strength, and direction of causal influences (Hamaker, Kuiper, & 
Grasman, 2015). This may be another reason why T1 PTSD symptoms were found to negatively 
predict T2 DSO symptoms. This limitation can be addressed using ‘multiple indicator random 
intercept cross-lagged panel modelling’, however, this approach necessitates data from a 
minimum of three assessments (Hamaker et al., 2015). Consequently, it was impossible to 
disentangle the within- and between-person effects in this study. Future research with additional 
follow up assessments will help to clarify the temporal associations between the PTSD and DSO 
symptoms. Finally, we were unable to determine if participants experienced any positive (e.g., 
mental health interventions) or negative (e.g., additional traumatic life events) life events during 
the assessments that may have influenced diagnostic rates and symptom levels at the follow up 
assessment.  
4.2 Conclusion 
In conclusion, this study provides novel evidence that PTSD and CPTSD are stable 
constructs at the symptom and diagnostic levels within the general population of Israel. In 
particular, the DSO symptoms were shown to be extremely stable across time and reinforced and 
intensified later PTSD symptoms. These findings are important as they suggest that there may be 
18 
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clinical value in developing evidenced-based psychological interventions to treat DSO 
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Table 1. Paired samples t-tests comparing mean symptom scores from Time 1 to Time 2 (n = 
543).  
  Mean SD t p* drm (95% CI) 
PTSD Time 1 4.32 5.04 3.34 .001 .14 (.02, .26) 
 Time 2 3.58 4.97    
Re-experiencing Time 1 1.21 1.69 1.75 .081 .08 (-.04, .19) 
 Time 2 1.06 1.69    
Avoidance Time 1 1.46 1.98 2.40 .017 .10 (.02, .22) 
 Time 2 1.24 1.98    
Sense of threat Time 1 1.66 2.17 3.97 < .001 .16 (.04, .28) 
 Time 2 1.28 1.95    
DSO Time 1 4.68 4.60 .43 .669 .02 (-.10, .14) 
 Time 2 4.61 4.87    
Affective dysregulation Time 1 2.18 1.79 1.75 .081 .07 (-.05, .19) 
 Time 2 2.05 1.78    
Negative self-concept Time 1 1.01 1.65 -1.33 .183 .06 (-.06, .18) 
 Time 2 1.10 1.80    
Disturbed relationships Time 1 1.50 1.93 .50 .615 .02 (-.10, .14) 
 Time 2 1.46 1.99    
Note. All degrees of freedom = 542; SD = standard deviation; PTSD = posttraumatic stress 
disorder; DSO = disturbance in self-organization; p* = statistical significance result with a 
Bonferroni correction (alpha level = .006); drm (95% CI) = Cohen’s d for repeated measures 
designs with 95% confidence intervals.  
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Table 2. Latent cross-lagged panel model results with covariates (N = 1,003). 
 χ2 df CFI TLI RMSEA (90% CI) SRMR AIC 
1a. Autoregressive paths only 357.35* 82 .929 .902 .058 (.052, .064) .048 33436 
1b. Autoregressive paths only 358.42* 86 .930 .907 .056 (.050, .062) .046 33432 
2a. Cross-lagged paths only 557.09* 82 .878 .830 .076 (.070, .082) .117 33695 
2b. Cross-lagged paths only 557.08* 86 .879 .840 .074 (.068, .080) .112 33693 
3a. Autoregressive and cross-lagged paths 346.03* 80 .932 .903 .058 (.051, .064) .042 33424 
3b. Autoregressive and cross-lagged paths 347.23* 84 .932 .908 .056 (.050, .062) .040 33420 
4a. Autoregressive and cross-lagged paths constrained equal 359.21* 81 .929 .900 .059 (.052, .065) .048 33438 
4b. Autoregressive and cross-lagged paths constrained equal 360.12* 85 .929 .905 .057 (.051, .063) .046 33433 
Note. Models 1a–4a = factor loadings are freely estimated; Models 1b–4b = factor loadings are constrained equal across time (test of 
metric invariance); χ2 = chi-square goodness of fit statistic; * indicates χ2 is statistically significant (p < .001); df = degrees of freedom; 
CFI = Comparative Fit Index; TLI = Tucker-Lewis Index; RMSEA (90% CI) = Root-Mean-Square Error of Approximation with 90% 
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Figure 1. Simplified illustrations of the four cross-lagged panel models (Models 1b – 4b). 
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Figure 2. Standardized coefficients from the metric invariant cross-lagged panel model of the associations between PTSD and DSO 
symptoms across a 12-month period controlling for multiple covariates. 
 
Note: PTSD = posttraumatic stress disorder; DSO = disturbances in self-organization; RE = reexperiencing in the here and now; AV = 
avoidance; TH = sense of threat; AD = affective dysregulation; NSC = negative self-concept; DR = disturbed relationships; statistical 
significance = *p < .05, **p < .01, ***p < .001; bold lines = autoregressive paths; dashed lines = cross-lagged paths; dotted lines = 
covariate effects. 
